|
Volumn 12, Issue 8, 2011, Pages 728-730
|
NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERLOTINIB;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NOTE;
ORGANIZATION;
UNITED KINGDOM;
CARCINOMA, NON-SMALL-CELL LUNG;
CONGRESSES AS TOPIC;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
GREAT BRITAIN;
HUMANS;
LUNG NEOPLASMS;
PROTEIN KINASE INHIBITORS;
QUINAZOLINES;
MLCS;
MLOWN;
|
EID: 80053438603
PISSN: None
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/s1470-2045(11)70177-2 Document Type: Note |
Times cited : (1)
|
References (0)
|